Clinical trial
Juvenile Rheumatoid Arthritis
NCT00037648 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00037648 |
|---|---|
| Title | Juvenile Rheumatoid Arthritis |
| Official title | A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Open-label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuIL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Juvenile Chronic Arthritis |
| Intervention type | Drug |
| Interventions | Anakinra, Placebo |
| Enrollment | 86 |
| Start date | Jul 1, 2000 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | May 20, 2002 |
| Last update posted | Nov 26, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: